Leaked documents show that some early commercial batches of Pfizer-BioNTech’s covid-19 vaccine had lower than expected levels of intact mRNA, prompting wider questions about how to assess this novel vaccine platform, writes Serena Tinari
Eurpean Medicines Agency
Browse the articles related to this topic below.
Join our community on Guilded.